Avandia-Being Pulled from Pharmacies by FDA

The U.S. Food and Drug Administration announced Wednesday that it would restrict access to GlaxoSmithKline PLC's diabetes drug Avandia and pull it from retail pharmacies because of the drug's link to increased risks of heart attack and stroke.

After Nov. 18, Avandia will no longer be available at pharmacies, and doctors and patients will need to enroll in an FDA program in order to prescribe and receive the medicine, according to the agency.

Comments

Popular posts from this blog

Safety for Your Family or Corporations?

New Report on Nursing Home Negligence

Supreme Court Knocks Down FDA Preemption